Volume 13, Issue 2 (March 2011) 13, 179–180; 10.1038/aja.2010.169

Epithelial–mesenchymal transition in prostate cancer: providing new targets for therapy

Andrew J Armstrong¹, Stephen J Freedland² and Mariano Garcia-Blanco³

1 Duke Cancer Institute, Departments of Medicine and Surgery, Duke Prostate Center, Duke University, Durham, NC 27710, USA
2 Section of Urology, Durham VA Medical Center, Duke Prostate Center, Division of Urologic Surgery, Departments of Surgery and Pathology, Duke University Medical Center, Durham, NC 27710, USA
3 Department of Molecular Genetics and Microbiology, Department of Medicine Center for RNA Biology, Duke University Medical Center, NC 27710, USA

Correspondence: Dr AJ Armstrong, (andrew.armstrong@duke.edu)

Advance online publication 1 March 2011